{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T20:42:50Z","timestamp":1767991370876,"version":"3.49.0"},"reference-count":83,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1097\/jcp.0b013e318270e2c7","type":"journal-article","created":{"date-parts":[[2012,11,6]],"date-time":"2012-11-06T10:17:20Z","timestamp":1352197040000},"page":"756-766","source":"Crossref","is-referenced-by-count":28,"title":["Electroconvulsive Therapy and Clozapine in Adolescents With Schizophrenia Spectrum Disorders"],"prefix":"10.1097","volume":"32","author":[{"given":"Itziar","family":"Flamarique","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josefina","family":"Castro-Fornieles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Miguel","family":"Garrido","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"de la Serna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandre","family":"Pons","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel","family":"Bernardo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inmaculada","family":"Baeza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-4-20210128","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1176\/appi.ajp.157.10.1652","article-title":"Adult outcomes of child- and adolescent-onset schizophrenia: diagnostic stability and predictive validity.","volume":"157","author":"Hollis","year":"2000","journal-title":"Am J Psychiatry"},{"key":"R2-4-20210128","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/BF02190734","article-title":"Epidemiology of early-onset schizophrenia.","volume":"245","author":"Hafner","year":"1995","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"R3-4-20210128","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1097\/YCO.0b013e32833b027e","article-title":"Treatment of early-onset schizophrenia.","volume":"23","author":"Mattai","year":"2010","journal-title":"Curr Opin Psychiatry"},{"key":"R4-4-20210128","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1093\/schbul\/sbm109","article-title":". Efficacy and tolerability of second-generation antipsychotics in children and adolescents with schizophrenia.","volume":"34","author":"Kumra","year":"2008","journal-title":"Schizophr Bull"},{"key":"R5-4-20210128","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1192\/S0007125000296918","article-title":"Clinical efficacy of clozapine in treatment-refractory schizophrenia: an overview.","volume":"17","author":"Kane","year":"1992","journal-title":"Br J Psychiatry Suppl"},{"key":"R6-4-20210128","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1001\/archpsyc.1988.01800330013001","article-title":". Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine.","volume":"45","author":"Kane","year":"1988","journal-title":"Arch Gen Psychiatry"},{"key":"R7-4-20210128","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/jcp.0b013e3180d0a6d4","article-title":". Early use of clozapine for poorly responding first-episode psychosis.","volume":"27","author":"Agid","year":"2007","journal-title":"J Clin Psychopharmacol"},{"key":"R8-4-20210128","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1176\/ajp.156.6.863","article-title":". Rehospitalization rates of patients recently discharged on a regimen of risperidone or clozapine.","volume":"156","author":"Conley","year":"1999","journal-title":"Am J Psychiatry"},{"key":"R9-4-20210128","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3109\/10401230309085667","article-title":". Rehospitalization risk with second-generation and depot antipsychotics.","volume":"15","author":"Conley","year":"2003","journal-title":"Ann Clin Psychiatry"},{"key":"R10-4-20210128","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/S1726-4901(09)70254-0","article-title":". Comparison of time to rehospitalization among schizophrenic patients discharged on typical antipsychotics, clozapine or risperidone.","volume":"69","author":"Lin","year":"2006","journal-title":"J Chin Med Assoc"},{"key":"R11-4-20210128","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1590\/S1516-44462007000300004","article-title":"Rehospitalization rates of patients with schizophrenia discharged on haloperidol, risperidone or clozapine.","volume":"29","author":"Castro","year":"2007","journal-title":"Rev Bras Psiquiatr"},{"key":"R12-4-20210128","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3325\/cmj.2008.2.215","article-title":". Two-year rehospitalization rates of patients with newly diagnosed or chronic schizophrenia on atypical or typical antipsychotic drugs: retrospective cohort study.","volume":"49","author":"Herceg","year":"2008","journal-title":"Croat Med J"},{"key":"R13-4-20210128","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.psychres.2011.04.004","article-title":". Time to rehospitalization in patients with schizophrenia discharged on first generation antipsychotics, non-clozapine second generation antipsychotics, or clozapine.","volume":"188","author":"Werneck","year":"2011","journal-title":"Psychiatry Res"},{"key":"R14-4-20210128","first-page":"89","article-title":". Clozapine reduces rehospitalization among schizophrenia patients.","volume":"34","author":"Pollack","year":"1998","journal-title":"Psychopharmacol Bull"},{"key":"R15-4-20210128","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1176\/jnp.23.2.jnp223","article-title":". Catatonia in psychotic patients: clinical features and treatment response.","volume":"23","author":"England","year":"2011","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"R17-4-20210128","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1007\/s001150050349","article-title":"Catatonic dilemma. Therapy with lorazepam and clozapine.","volume":"69","author":"Lausberg","year":"1998","journal-title":"Nervenarzt"},{"key":"R18-4-20210128","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.euroneuro.2010.07.002","article-title":". Efficacy and safety of second-generation antipsychotics in children and adolescents with psychotic and bipolar spectrum disorders: comprehensive review of prospective head-to-head and placebo-controlled comparisons.","volume":"21","author":"Fraguas","year":"2011","journal-title":"Eur Neuropsychopharmacol"},{"key":"R19-4-20210128","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1001\/archpsyc.63.7.721","article-title":". Childhood-onset schizophrenia: a double-blind, randomized clozapine-olanzapine comparison.","volume":"63","author":"Shaw","year":"2006","journal-title":"Arch Gen Psychiatry"},{"key":"R20-4-20210128","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/01.chi.0000145371.23122.5a","article-title":". Clozapine: its impact on aggressive behavior among children and adolescents with schizophrenia.","volume":"44","author":"Kranzler","year":"2005","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"R21-4-20210128","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1097\/chi.0b013e31812eed10","article-title":". Clozapine treatment of childhood-onset schizophrenia: evaluation of effectiveness, adverse effects, and long-term outcome.","volume":"46","author":"Sporn","year":"2007","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"R22-4-20210128","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1517\/14656566.9.3.459","article-title":"Clozapine use in children and adolescents.","volume":"9","author":"Gogtay","year":"2008","journal-title":"Expert Opin Pharmacother"},{"key":"R23-4-20210128","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/S0006-3223(96)00298-3","article-title":"Clozapine-induced electroencephalogram changes as a function of clozapine serum levels.","volume":"42","author":"Freudenreich","year":"1997","journal-title":"Biol Psychiatry"},{"key":"R24-4-20210128","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/0006-3223(95)00499-8","article-title":"Clozapine-induced myoclonus and generalized seizures.","volume":"39","author":"Sajatovic","year":"1996","journal-title":"Biol Psychiatry"},{"key":"R25-4-20210128","first-page":"96","article-title":"Agranulocytosis monitoring with clozapine patients: to follow guidelines or to attempt therapeutic controversies Singapore Med J.","volume":"49","author":"Chandrasekaran","year":"2008","journal-title":""},{"key":"R26-4-20210128","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1192\/bjp.175.6.576","article-title":". Active monitoring of 12,760 clozapine recipients in the UK and Ireland. Beyond pharmacovigilance.","volume":"175","author":"Munro","year":"1999","journal-title":"Br J Psychiatry"},{"key":"R27-4-20210128","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1192\/bjp.169.4.483","article-title":". Neutropenia and agranulocytosis in patients receiving clozapine in the UK and Ireland.","volume":"169","author":"Atkin","year":"1996","journal-title":"Br J Psychiatry"},{"key":"R28-4-20210128","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1097\/JCP.0b013e3181dbfc22","article-title":"Use of clozapine in an adolescent with refractory first-episode psychosis and neutropenia.","volume":"30","author":"Ragonnet","year":"2010","journal-title":"J Clin Psychopharmacol"},{"key":"R29-4-20210128","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/00124509-200603000-00002","article-title":"ECT for treatment-resistant schizophrenia: a response from the Far East to the UK. NICE report.","volume":"22","author":"Chanpattana","year":"2006","journal-title":"J ECT"},{"key":"R30-4-20210128","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1089\/cap.2009.0066","article-title":". Clinical experience using electroconvulsive therapy in adolescents with schizophrenia spectrum disorders.","volume":"20","author":"Baeza","year":"2010","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"R31-4-20210128","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1097\/YCT.0b013e3181a2f836","article-title":". Electroconvulsive therapy in early adolescents with schizophrenia spectrum disorders.","volume":"25","author":"Baeza","year":"2009","journal-title":"J ECT"},{"key":"R32-4-20210128","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1620\/tjem.210.213","article-title":". Improvement of psychiatric symptoms after electroconvulsive therapy in young adults with intractable first-episode schizophrenia and schizophreniform disorder.","volume":"210","author":"Suzuki","year":"2006","journal-title":"Tohoku J Exp Med"},{"key":"R33-4-20210128","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1097\/01.chi.0000142280.87429.68","article-title":". Practice parameter for use of electroconvulsive therapy with adolescents.","volume":"43","author":"Ghaziuddin","year":"2004","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"R34-4-20210128","first-page":"349","article-title":"Electroconvulsive therapy in children and adolescents: a review of the literature.","volume":"122","author":"Domenech","year":"2004","journal-title":"Med Clin (Barc)"},{"key":"R35-4-20210128","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1097\/00004583-200111000-00014","article-title":". Electroconvulsive therapy in adolescents: similarities to and differences from adults.","volume":"40","author":"Bloch","year":"2001","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"R36-4-20210128","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/1469-7610.00450","article-title":"Practitioner review: electroconvulsive therapy in adolescents.","volume":"40","author":"Walter","year":"1999","journal-title":"J Child Psychol Psychiatry"},{"key":"R37-4-20210128","first-page":"25","article-title":"Use of electroconvulsive therapy in adolescents.","volume":"13","author":"Cohen","year":"1997","journal-title":"Convuls Ther"},{"key":"R38-4-20210128","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1097\/00004583-199603000-00012","article-title":"Case study: electroconvulsive therapy in adolescents.","volume":"35","author":"Moise","year":"1996","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"R39-4-20210128","first-page":"158","article-title":"Electroconvulsive therapy in adolescents.","volume":"9","author":"Schneekloth","year":"1993","journal-title":"Convuls Ther"},{"key":"R40-4-20210128","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1080\/10398560801886039","article-title":". Reasons for referral for electroconvulsive therapy: a comparison between adolescents and adults.","volume":"16","author":"Bloch","year":"2008","journal-title":"Australas Psychiatry"},{"key":"R41-4-20210128","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/S0924-9338(02)00668-5","article-title":". Clinical relevance of electroconvulsive therapy (ECT) in adolescents with severe mood disorder: evidence from a follow-up study.","volume":"17","author":"Taieb","year":"2002","journal-title":"Eur Psychiatry"},{"key":"R42-4-20210128","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1097\/01.yct.0000188623.05778.d3","article-title":". Long-term follow-up in depressed patients treated with electroconvulsive therapy.","volume":"21","author":"Johanson","year":"2005","journal-title":"J ECT"},{"key":"R43-4-20210128","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1089\/cap.2011.0012","article-title":"Elena, Flamarique I, Castro-Fornieles J, et al.. Two-year follow-up of cognitive functions in schizophrenia spectrum disorders of adolescent patients treated with ECT.","volume":"21","year":"2011","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"R44-4-20210128","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1176\/appi.ajp.157.3.460","article-title":". Absence of cognitive impairment at long-term follow-up in adolescents treated with ECT for severe mood disorder.","volume":"157","author":"Cohen","year":"2000","journal-title":"Am J Psychiatry"},{"key":"R45-4-20210128","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1176\/ajp.154.5.595","article-title":"Half a century of ECT use in young people.","volume":"154","author":"Rey","year":"1997","journal-title":"Am J Psychiatry"},{"key":"R46-4-20210128","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1001\/archpsyc.1990.01810150090018","article-title":"Clozapine and electroconvulsive therapy.","volume":"47","author":"Fink","year":"1990","journal-title":"Arch Gen Psychiatry"},{"key":"R47-4-20210128","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0920-9964(90)90021-X","article-title":"Combined electroconvulsive and neuroleptic therapy in schizophrenia refractory to neuroleptics.","volume":"3","author":"Konig","year":"1990","journal-title":"Schizophr Res"},{"key":"R48-4-20210128","first-page":"176","article-title":"Combined clozapine and electroconvulsive therapy.","volume":"9","author":"Frankenburg","year":"1993","journal-title":"Convuls Ther"},{"key":"R49-4-20210128","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1097\/00002826-200601000-00012","article-title":". Concurrent administration of clozapine and electroconvulsive therapy in clozapine-resistant schizophrenia.","volume":"29","author":"Havaki-Kontaxaki","year":"2006","journal-title":"Clin Neuropharmacol"},{"key":"R50-4-20210128","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/00002826-200001000-00003","article-title":". Combined electroconvulsive-clozapine therapy.","volume":"23","author":"Kupchik","year":"2000","journal-title":"Clin Neuropharmacol"},{"key":"R51-4-20210128","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1080\/15622970500395280","article-title":". The influence of concomitant neuroleptic medication on safety, tolerability and clinical effectiveness of electroconvulsive therapy.","volume":"7","author":"Nothdurfter","year":"2006","journal-title":"World J Biol Psychiatry"},{"key":"R52-4-20210128","doi-asserted-by":"crossref","first-page":"4287","DOI":"10.3923\/pjbs.2007.4287.4290","article-title":"Comparative study of clozapine, electroshock and the combination of ECT with clozapine in treatment-resistant schizophrenic patients.","volume":"10","author":"Masoudzadeh","year":"2007","journal-title":"Pak J Biol Sci"},{"key":"R53-4-20210128","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.eurpsy.2009.04.005","article-title":"ECT rekindles pharmacological response in schizophrenia.","volume":"24","author":"Hustig","year":"2009","journal-title":"Eur Psychiatry"},{"key":"R54-4-20210128","first-page":"388","article-title":". Clozapine following ECT: a two-step treatment.","volume":"55","author":"Green","year":"1994","journal-title":"J Clin Psychiatry"},{"key":"R55-4-20210128","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/00004850-199903000-00002","article-title":"Elective combined electroconvulsive and clozapine therapy.","volume":"14","author":"James","year":"1999","journal-title":"Int Clin Psychopharmacol"},{"key":"R56-4-20210128","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/j.1440-1819.2006.01495.x","article-title":"Clozapine in schizophrenia patients with recurrent catatonia: report of two cases.","volume":"60","author":"Hung","year":"2006","journal-title":"Psychiatry Clin Neurosci"},{"key":"R57-4-20210128","first-page":"385","article-title":". The impact of neuroleptic medication on seizure threshold and duration in electroconvulsive therapy.","volume":"57","author":"Gazdag","year":"2004","journal-title":"Ideggyogy Sz"},{"key":"R58-4-20210128","first-page":"253","article-title":"Should the administration of ECT during clozapine therapy be contraindicated Br J Psychiatry.","volume":"169","author":"Bloch","year":"1996","journal-title":""},{"key":"R59-4-20210128","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0924-9338(96)89901-9","article-title":"Safety and effectiveness of combined ECT and clozapine in treatment-resistant mania.","volume":"11","author":"Poyurovsky","year":"1996","journal-title":"Eur Psychiatry"},{"key":"R61-4-20210128","first-page":"141","article-title":"Combining clozapine with ECT.","volume":"8","author":"Safferman","year":"1992","journal-title":"Convuls Ther"},{"key":"R62-4-20210128","first-page":"303","article-title":"Follow-up on clozapine and ECT.","volume":"7","author":"Klapheke","year":"1991","journal-title":"Convuls Ther"},{"key":"R63-4-20210128","first-page":"218","article-title":"Combined use of clozapine and electroconvulsive therapy.","volume":"7","author":"Landy","year":"1991","journal-title":"Convuls Ther"},{"key":"R64-4-20210128","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/YCT.0b013e3181a2f867","article-title":"Very high-dose clozapine and electroconvulsive therapy combination treatment in a patient with schizophrenia.","volume":"25","author":"Keller","year":"2009","journal-title":"J ECT"},{"key":"R65-4-20210128","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/01.yct.0000165500.60784.05","article-title":"The combined use of electroconvulsive therapy and antipsychotics in patients with schizophrenia.","volume":"21","author":"Braga","year":"2005","journal-title":"J ECT"},{"key":"R66-4-20210128","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1007\/s00406-004-0517-y","article-title":"Blansjaar BA, de VS, et al.. Electroconvulsive therapy for the treatment of clozapine nonresponders suffering from schizophreniaan open label study.","volume":"254","author":"Kho","year":"2004","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"R67-4-20210128","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0278-5846(99)00015-9","article-title":"Combined electroconvulsive therapy and clozapine in treatment-resistant schizophrenia.","volume":"23","author":"Kales","year":"1999","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"R68-4-20210128","first-page":"117","article-title":"Neuroleptic-resistant schizophrenia treated with clozapine and ECT.","volume":"12","author":"Benatov","year":"1996","journal-title":"Convuls Ther"},{"key":"R69-4-20210128","first-page":"110","article-title":"Seizure activity in combined clozapine and ECT: a retrospective view.","volume":"11","author":"Cardwell","year":"1995","journal-title":"Convuls Ther"},{"key":"R70-4-20210128","doi-asserted-by":"crossref","first-page":"775","DOI":"10.4088\/JCP.08m04971gre","article-title":". Influence of anesthetic drugs and concurrent psychiatric medication on seizure adequacy during electroconvulsive therapy.","volume":"71","author":"Bundy","year":"2010","journal-title":"J Clin Psychiatry"},{"key":"R71-4-20210128","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1097\/YCT.0b013e31819c76ff","article-title":". Seizure threshold in a large sample: implications for stimulus dosing strategies in bilateral electroconvulsive therapy: a report from CORE.","volume":"25","author":"Petrides","year":"2009","journal-title":"J ECT"},{"key":"R72-4-20210128","first-page":"99","article-title":"Seizure threshold and ECT. Importance for good clinical practice of ECT. A review of literature.","volume":"29","author":"Poulet","year":"2003","journal-title":"Encephale"},{"key":"R73-4-20210128","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/00124509-199903000-00003","article-title":"The anticonvulsant hypothesis of the mechanisms of action of ECT: current status.","volume":"15","author":"Sackeim","year":"1999","journal-title":"J ECT"},{"key":"R74-4-20210128","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/YCT.0b013e31818a0203","article-title":". Comparison of propofol and thiopental as anesthetic agents for electroconvulsive therapy: a randomized, blinded comparison of seizure duration, stimulus charge, clinical effect, and cognitive side effects.","volume":"25","author":"Bauer","year":"2009","journal-title":"J ECT"},{"key":"R75-4-20210128","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1007\/s00787-008-0724-6","article-title":". Moderate clinical improvement with maintenance ECT in a 17-year-old boy with intractable catatonic schizophrenia.","volume":"18","author":"Consoli","year":"2009","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"R76-4-20210128","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1089\/cap.2005.15.844","article-title":". Neuroleptic malignant syndrome associated with risperidone in a male with early-onset schizophrenia.","volume":"15","author":"Mane","year":"2005","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"R78-4-20210128","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/YCT.0b013e3181efa1b2","article-title":"A review of continuation electroconvulsive therapy: application, safety, and efficacy.","volume":"26","author":"Trevino","year":"2010","journal-title":"J ECT"},{"key":"R79-4-20210128","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia.","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr Bull"},{"key":"R80-4-20210128","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0165-1781(94)90093-0","article-title":"Psychometric properties of the positive and negative syndrome scale (PANSS) in schizophrenia.","volume":"53","author":"Peralta","year":"1994","journal-title":"Psychiatry Res"},{"key":"R82-4-20210128","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1176\/appi.ajp.162.5.947","article-title":". Risperidone and haloperidol in first-episode psychosis: a long-term randomized trial.","volume":"162","author":"Schooler","year":"2005","journal-title":"Am J Psychiatry"},{"key":"R83-4-20210128","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s002130050028","article-title":". Relationship between plasma concentrations of clozapine and norclozapine and therapeutic response in patients with schizophrenia resistant to conventional neuroleptics.","volume":"148","author":"Spina","year":"2000","journal-title":"Psychopharmacology (Berl)"},{"key":"R84-4-20210128","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1176\/ajp.155.4.499","article-title":". Risperidone versus clozapine in treatment-resistant chronic schizophrenia: a randomized double-blind study. The Risperidone Study Group.","volume":"155","author":"Bondolfi","year":"1998","journal-title":"Am J Psychiatry"},{"key":"R85-4-20210128","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1093\/oxfordjournals.schbul.a033333","article-title":"Management of the adverse effects of clozapine.","volume":"24","author":"Young","year":"1998","journal-title":"Schizophr Bull"},{"key":"R86-4-20210128","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/00124509-200603000-00008","article-title":"Electroconvulsive therapy in first-episode schizophrenia.","volume":"22","author":"Ucok","year":"2006","journal-title":"J ECT"},{"key":"R87-4-20210128","first-page":"683","article-title":". Clozapines effectiveness for patients in state hospitals: results from a randomized trial.","volume":"32","author":"Essock","year":"1996","journal-title":"Psychopharmacol Bull"}],"container-title":["Journal of Clinical Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/JCP.0b013e318270e2c7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:00:22Z","timestamp":1620957622000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00004714-201212000-00004"}},"subtitle":["Is It a Safe and Effective Combination?"],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":83,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/jcp.0b013e318270e2c7","relation":{},"ISSN":["0271-0749"],"issn-type":[{"value":"0271-0749","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12]]}}}